Avinger(AVGR) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Avinger Reports Third Quarter 2024 Results Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin Redwood City, Calif., November 7, 2024 - Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the third quarter ended September 30, 2024. Third Quarter and Recent Highlights ● Reported ...